Expression of hypoxia-inducible factor 1α in thyroid carcinomasCitation formats

  • External authors:
  • N. Burrows
  • J. Resch
  • R. Von Wasielewski
  • C. Hoang-Vu
  • G. Brabant

Standard

Expression of hypoxia-inducible factor 1α in thyroid carcinomas. / Burrows, N.; Resch, J.; Cowen, R. L.; Von Wasielewski, R.; Hoang-Vu, C.; West, C. M.; Williams, K. J.; Brabant, G.

In: Endocrine-related cancer, Vol. 17, No. 1, 03.2010, p. 61-72.

Research output: Contribution to journalArticlepeer-review

Harvard

Burrows, N, Resch, J, Cowen, RL, Von Wasielewski, R, Hoang-Vu, C, West, CM, Williams, KJ & Brabant, G 2010, 'Expression of hypoxia-inducible factor 1α in thyroid carcinomas', Endocrine-related cancer, vol. 17, no. 1, pp. 61-72. https://doi.org/10.1677/ERC-08-0251

APA

Burrows, N., Resch, J., Cowen, R. L., Von Wasielewski, R., Hoang-Vu, C., West, C. M., Williams, K. J., & Brabant, G. (2010). Expression of hypoxia-inducible factor 1α in thyroid carcinomas. Endocrine-related cancer, 17(1), 61-72. https://doi.org/10.1677/ERC-08-0251

Vancouver

Burrows N, Resch J, Cowen RL, Von Wasielewski R, Hoang-Vu C, West CM et al. Expression of hypoxia-inducible factor 1α in thyroid carcinomas. Endocrine-related cancer. 2010 Mar;17(1):61-72. https://doi.org/10.1677/ERC-08-0251

Author

Burrows, N. ; Resch, J. ; Cowen, R. L. ; Von Wasielewski, R. ; Hoang-Vu, C. ; West, C. M. ; Williams, K. J. ; Brabant, G. / Expression of hypoxia-inducible factor 1α in thyroid carcinomas. In: Endocrine-related cancer. 2010 ; Vol. 17, No. 1. pp. 61-72.

Bibtex

@article{cbd270c52b834308b51cac064c45584a,
title = "Expression of hypoxia-inducible factor 1α in thyroid carcinomas",
abstract = "Hypoxia-inducible factor 1α (HIF-1α) is upregulated by hypoxia and oncogenic signalling in many solid tumours. Its regulation and function in thyroid carcinomas are unknown. We evaluated the regulation of HIF-1α and target gene expression in primary thyroid carcinomas and thyroid carcinoma cell lines (BcPAP, WRO, FTC-133 and 8505c). HIF-1α was not detectable in normal tissue but was expressed in thyroid carcinomas. Dedifferentiated anaplastic tumours (ATCs) exhibited high levels of nuclear HIF-1α staining. The HIF-1 target glucose transporter 1 was expressed to a similar level in all tumour types, whereas carbonic anhydrase-9 was significantly elevated in ATCs. In vitro studies revealed a functionally active HIF-1α pathway in thyroid cells with transcriptional activation observed after graded hypoxia (1% O2, anoxia) or treatment with a hypoxia mimetic cobalt chloride. High basal and hypoxia-induced expression of HIF-1α in FTC-133 cells that harbour a phosphatase and tensin homologue (PTEN) mutation was reduced by introduction of wild-type PTEN. Similarly, pharmacological inhibition of the phosphoinositide 3-kinase (PI3K) pathway using LY294002 inhibited HIF-1α and HIF-1α targets in all cell lines, including those with B-RAF mutations (BcPAP and 8505c). In contrast, the effects of inhibition of the RAF/MEK/extracellular signal-regulated kinase pathway were restricted by environmental condition and B-RAF mutation status. HIF-1 is functionally expressed in thyroid carcinomas and is regulated not only by hypoxia but also via growth factor signalling pathways and, in particular, the PI3K pathway. Given the strong association of HIF-1α with an aggressive disease phenotype and therapeutic resistance, this pathway may be an attractive target for improved therapy in thyroid carcinomas. {\textcopyright} 2010 Society for Endocrinology.",
author = "N. Burrows and J. Resch and Cowen, {R. L.} and {Von Wasielewski}, R. and C. Hoang-Vu and West, {C. M.} and Williams, {K. J.} and G. Brabant",
note = "C7820/A8696, Cancer Research UK, United Kingdom",
year = "2010",
month = mar,
doi = "10.1677/ERC-08-0251",
language = "English",
volume = "17",
pages = "61--72",
journal = "Endocrine - Related Cancer",
issn = "1351-0088",
publisher = "Society for Endocrinology",
number = "1",

}

RIS

TY - JOUR

T1 - Expression of hypoxia-inducible factor 1α in thyroid carcinomas

AU - Burrows, N.

AU - Resch, J.

AU - Cowen, R. L.

AU - Von Wasielewski, R.

AU - Hoang-Vu, C.

AU - West, C. M.

AU - Williams, K. J.

AU - Brabant, G.

N1 - C7820/A8696, Cancer Research UK, United Kingdom

PY - 2010/3

Y1 - 2010/3

N2 - Hypoxia-inducible factor 1α (HIF-1α) is upregulated by hypoxia and oncogenic signalling in many solid tumours. Its regulation and function in thyroid carcinomas are unknown. We evaluated the regulation of HIF-1α and target gene expression in primary thyroid carcinomas and thyroid carcinoma cell lines (BcPAP, WRO, FTC-133 and 8505c). HIF-1α was not detectable in normal tissue but was expressed in thyroid carcinomas. Dedifferentiated anaplastic tumours (ATCs) exhibited high levels of nuclear HIF-1α staining. The HIF-1 target glucose transporter 1 was expressed to a similar level in all tumour types, whereas carbonic anhydrase-9 was significantly elevated in ATCs. In vitro studies revealed a functionally active HIF-1α pathway in thyroid cells with transcriptional activation observed after graded hypoxia (1% O2, anoxia) or treatment with a hypoxia mimetic cobalt chloride. High basal and hypoxia-induced expression of HIF-1α in FTC-133 cells that harbour a phosphatase and tensin homologue (PTEN) mutation was reduced by introduction of wild-type PTEN. Similarly, pharmacological inhibition of the phosphoinositide 3-kinase (PI3K) pathway using LY294002 inhibited HIF-1α and HIF-1α targets in all cell lines, including those with B-RAF mutations (BcPAP and 8505c). In contrast, the effects of inhibition of the RAF/MEK/extracellular signal-regulated kinase pathway were restricted by environmental condition and B-RAF mutation status. HIF-1 is functionally expressed in thyroid carcinomas and is regulated not only by hypoxia but also via growth factor signalling pathways and, in particular, the PI3K pathway. Given the strong association of HIF-1α with an aggressive disease phenotype and therapeutic resistance, this pathway may be an attractive target for improved therapy in thyroid carcinomas. © 2010 Society for Endocrinology.

AB - Hypoxia-inducible factor 1α (HIF-1α) is upregulated by hypoxia and oncogenic signalling in many solid tumours. Its regulation and function in thyroid carcinomas are unknown. We evaluated the regulation of HIF-1α and target gene expression in primary thyroid carcinomas and thyroid carcinoma cell lines (BcPAP, WRO, FTC-133 and 8505c). HIF-1α was not detectable in normal tissue but was expressed in thyroid carcinomas. Dedifferentiated anaplastic tumours (ATCs) exhibited high levels of nuclear HIF-1α staining. The HIF-1 target glucose transporter 1 was expressed to a similar level in all tumour types, whereas carbonic anhydrase-9 was significantly elevated in ATCs. In vitro studies revealed a functionally active HIF-1α pathway in thyroid cells with transcriptional activation observed after graded hypoxia (1% O2, anoxia) or treatment with a hypoxia mimetic cobalt chloride. High basal and hypoxia-induced expression of HIF-1α in FTC-133 cells that harbour a phosphatase and tensin homologue (PTEN) mutation was reduced by introduction of wild-type PTEN. Similarly, pharmacological inhibition of the phosphoinositide 3-kinase (PI3K) pathway using LY294002 inhibited HIF-1α and HIF-1α targets in all cell lines, including those with B-RAF mutations (BcPAP and 8505c). In contrast, the effects of inhibition of the RAF/MEK/extracellular signal-regulated kinase pathway were restricted by environmental condition and B-RAF mutation status. HIF-1 is functionally expressed in thyroid carcinomas and is regulated not only by hypoxia but also via growth factor signalling pathways and, in particular, the PI3K pathway. Given the strong association of HIF-1α with an aggressive disease phenotype and therapeutic resistance, this pathway may be an attractive target for improved therapy in thyroid carcinomas. © 2010 Society for Endocrinology.

U2 - 10.1677/ERC-08-0251

DO - 10.1677/ERC-08-0251

M3 - Article

C2 - 19808899

VL - 17

SP - 61

EP - 72

JO - Endocrine - Related Cancer

JF - Endocrine - Related Cancer

SN - 1351-0088

IS - 1

ER -